← All trials
NCT00162812
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2003
- Primary completion
- Dec 1, 2008
- Completion date
- Apr 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 338
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Free University of BrusselsLead sponsor
- University of CreteCollaborator
- Free University of BrusselsOverall official - principal investigator
- Free University of BrusselsStudy chair
- Centre Paul StraussCollaborator
- Centre Hospitalier de LuxembourgCollaborator
- HIS - Site Etterbeek - Ixelles - BelgiumCollaborator
- Clinique Louis Cathy, Baudour, BelgiumCollaborator
- CHU UCL NamurCollaborator
- University of Sao PauloCollaborator
- Free University of BrusselsCollaborator
- Institut Gustave RoussyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.